haploidentical

haploidentical

/hap·lo·iden·ti·cal/ (hap″lo-i-den´tĭ-k'l) sharing a haplotype; having the same alleles at a set of closely linked genes on one chromosome.
Mentioned in ?
References in periodicals archive ?
According to Bellicum, "lead product candidate BPX-501 is an adjunct T-cell therapy being evaluated in children and adults following a Tdepleted, haploidentical hematopoietic stem cell transplant (HSCT), with encouraging results.
According to Bellicum, "lead product candidate BPX-501 is an adjunct T-cell therapy being evaluated in children and adults following a T-depleted, haploidentical hematopoietic stem cell transplant (HSCT), with encouraging results.
Later, he underwent a Haploidentical stem cell transplant - where the donor is a part match to the recipient - from his 27-year-old brother, Hardeep.
Results from 47 patients demonstrated that administering BPX-501 following an alpha/beta T-cell depleted haploidentical hematopoietic stem cell transplant (alpha/beta T-cell depleted haplo-HSCT) produced rapid immune reconstitution, low incidence of acute and chronic Graft versus Host Disease (GvHD), and a low rate of disease relapse.
sup][15],[16] reported the efficacy of imatinib in preventing hematological relapse and improving LFS when administered to Ph+ ALL patients after allo-SCT with haploidentical or matched unrelated donors without ex vivo T-cell depletion.
To date, 15 patients have been recruited into the trial of which ten have received one or two doses of ATIR101 after their haploidentical stem cell transplantation (HSCT).
Multiple viral infections after haploidentical hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia.
Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice," Biochemical and Biophysical Research Communications, vol.
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells," The Lancet, vol.
Ringden, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439-144 (2004).
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.